134 related articles for article (PubMed ID: 35007895)
1. Treatment for Epstein-Barr Virus-associated uveitis confirmed by polymerase chain reaction: Efficacy of Anti-Viral Agents and a literature review.
Silpa-Archa S; Sriyuttagrai W; Foster CS
J Clin Virol; 2022 Feb; 147():105079. PubMed ID: 35007895
[TBL] [Abstract][Full Text] [Related]
2. Polymerase Chain Reaction and Goldmann-Witmer Coefficient to Examine the Role of Epstein-Barr Virus in Uveitis.
Smit D; Meyer D; Maritz J; de Groot-Mijnes JDF
Ocul Immunol Inflamm; 2019; 27(1):108-113. PubMed ID: 29039992
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus Uveitis Confirmed via Aqueous Humor Polymerase Chain Reaction and Metagenomics-A Case Report.
Hsia NY; Bair H; Lin CY; Lin CJ; Lai CT; Chang CM; Lin JM; Tsai YY
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256358
[TBL] [Abstract][Full Text] [Related]
4. A therapeutic trial of valganciclovir in patients with uveitis and positive Epstein-Barr virus early antigen D IgG titers.
Boonsopon S; Maghsoudlou A; Kombo NE; Foster CS
Eur J Ophthalmol; 2016; 26(1):30-5. PubMed ID: 26350994
[TBL] [Abstract][Full Text] [Related]
5. The Usefulness of Aqueous Fluid Analysis for Epstein-Barr Virus in Patients with Uveitis.
Groen-Hakan F; Van Der Eijk AA; Rothova A
Ocul Immunol Inflamm; 2020; 28(1):126-132. PubMed ID: 30422054
[No Abstract] [Full Text] [Related]
6. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
Barkholt L; Linde A; Falk KI
Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
[TBL] [Abstract][Full Text] [Related]
8. Successful Treatment of Necrotizing Retinitis with Epstein-Barr Virus-Positive Ocular Fluid by Intravitreal Methotrexate Injection.
Mashima A; Usui Y; Umazume K; Muramatsu D; Goto H
Ocul Immunol Inflamm; 2020 May; 28(4):552-555. PubMed ID: 31268776
[TBL] [Abstract][Full Text] [Related]
9. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
[TBL] [Abstract][Full Text] [Related]
10. Impact of valganciclovir on Epstein-Barr Virus polymerase chain reaction in pediatric liver transplantation: preliminary report.
Venturi C; Bueno J; Gavalda J; Tórtola T; Pou L; Medina A; Codina G; Charco R; Pahissa A
Transplant Proc; 2009 Apr; 41(3):1038-40. PubMed ID: 19376420
[TBL] [Abstract][Full Text] [Related]
11. [Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection].
Babel N; Hammer MH; Reinke P
Dtsch Med Wochenschr; 2003 Mar; 128(11):548-50. PubMed ID: 12635027
[TBL] [Abstract][Full Text] [Related]
12. The treatment of HSV1 ocular infections using quantitative real-time PCR results.
Hlinomazová Z; Loukotová V; Horáčková M; Šerý O
Acta Ophthalmol; 2012 Aug; 90(5):456-60. PubMed ID: 20553233
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children.
Green M; Kaufmann M; Wilson J; Reyes J
Clin Infect Dis; 1997 Dec; 25(6):1344-9. PubMed ID: 9431375
[TBL] [Abstract][Full Text] [Related]
14. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
Mentzer SJ; Perrine SP; Faller DV
Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
[TBL] [Abstract][Full Text] [Related]
15. Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis.
Yamamoto S; Sugita S; Sugamoto Y; Shimizu N; Morio T; Mochizuki M
Jpn J Ophthalmol; 2008; 52(6):463-467. PubMed ID: 19089567
[TBL] [Abstract][Full Text] [Related]
16. Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.
Faller DV; Mentzer SJ; Perrine SP
Curr Opin Oncol; 2001 Sep; 13(5):360-7. PubMed ID: 11555713
[TBL] [Abstract][Full Text] [Related]
17. Stromal keratitis and anterior uveitis due to herpes simplex virus-2 in a young child.
Inoda S; Wakakura M; Hirata J; Nakazato N; Toyo-Oka Y
Jpn J Ophthalmol; 2001; 45(6):618-21. PubMed ID: 11754904
[TBL] [Abstract][Full Text] [Related]
18. Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase.
Drosu NC; Edelman ER; Housman DE
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12368-12374. PubMed ID: 32409608
[TBL] [Abstract][Full Text] [Related]
19. [AIDS-related primary CNS non-Hodgkin's lymphoma in a patient with previous Epstein-Barr virus panuveitis. A clinico-pathological report].
Ruiz-Bilbao S; Hernández À; Gómez-Sánchez S; Romeu J; Llobera L L; Carrato C; Anglada R; Sabala A; Matas L
Arch Soc Esp Oftalmol; 2015 May; 90(5):241-3. PubMed ID: 25443210
[TBL] [Abstract][Full Text] [Related]
20. Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab.
Gill H; Hwang YY; Chan TS; Pang AW; Leung AY; Tse E; Kwong YL
J Clin Virol; 2014 Apr; 59(4):255-8. PubMed ID: 24507802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
